Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Satellos Bioscience Inc T.MSCL

Alternate Symbol(s):  MSCLF

Healthcare Biotechnology
Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and... see more

Recent & Breaking News (TSX:MSCL)

Satellos Bioscience Announces Significant Increase in Muscle Size and Function in Duchenne Muscular Dystrophy Disease Model

Newsfile February 6, 2023

Satellos Bioscience Announces Development Candidate

Newsfile January 3, 2023

Satellos Bioscience Announces Q3 2022 Financial Results and Operational Highlights

Newsfile November 23, 2022

Satellos Bioscience (TSXV:MSCL) advances compounds to the next stage of development

Brieanna McCutcheon  November 3, 2022

Satellos Bioscience Announces Advancement of Compounds to Next Stage of Development

Newsfile November 3, 2022

Satellos Bioscience Inc. to Present Preliminary Preclinical Proof of Concept Data for an Additional Rare Disease at World Muscle Society Meeting

Newsfile October 11, 2022

Satellos Bioscience (TSXV:MSCL) releases new licensing of formulation technology with NW PharmaTech

Brieanna McCutcheon  October 7, 2022

Satellos Bioscience Inc. Announces the Grant of Stock Options

Newsfile October 6, 2022

Satellos Bioscience Inc. Announces Licensing of Formulation Technology and Expanded Collaboration with NW PharmaTech Ltd.

Newsfile October 6, 2022

Satellos Bioscience (TSXV:MSCL) announces OTCQB listing

Azuka Onwuka October 6, 2022

Satellos Bioscience Announces OTCQB Listing in the United States

Newsfile October 6, 2022

Satellos Bioscience (TSXV:MSCL) appoints new Chief Technology Officer

Shoran Devi September 28, 2022

Satellos Bioscience Inc. Announces the Appointment of Philip D. Lambert, Ph.D, as Chief Technology Officer

Newsfile September 28, 2022

Satellos Bioscience (TSXV:MSCL) closes public offering

John Ballem  September 13, 2022

Satellos Bioscience Inc. Announces Closing of Offering of Units

Newsfile September 13, 2022

Satellos Bioscience Inc. Announces the Filing of Final Short Form Prospectus for Proposed Offering of Units

Newsfile September 7, 2022

Satellos Bioscience Inc. Announces Pricing of Proposed Offering of Units

Newsfile August 30, 2022

Satellos Bioscience Inc. Announces the Filing of an Amended and Restated Preliminary Prospectus for Proposed Offering of Units

Newsfile August 29, 2022

Satellos Bioscience Reports Q2 2022 Financials and Operating Results

Newsfile August 29, 2022

Satellos Bioscience (TSXV:MSCL) awarded grant from the Canadian Institutes of Health Research

Sabrina Cuthbert July 25, 2022